Semaglutide has emerged as a novel treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to release more insulin and curbing glucagon https://nellnuid785176.blog-a-story.com/16692445/understanding-semaglutide-a-comprehensive-guide